Observational Study of Golimumab Intravenous Infusion
NCT02390700
·
clinicaltrials.gov ↗
TERMINATED
Status
78
Enrollment
INDUSTRY
Sponsor class
Stopped
Business decision based on lack of enrollment
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
Golimumab Intravenous
Sponsor
Janssen Inc.